Dan Ezra Berkowitz

Dan Berkowitz practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dan Berkowitz's NPI, 1689639585, was assigned on April 20, 2006. Dan Berkowitz holds Alabama license L.4906DP.

Dan Berkowitz's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 934-6600.

Dan Berkowitz's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dan Berkowitz is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dan Berkowitz practices. Vendor and product names are available with a free account.

Anesthesiology is Dan Berkowitz's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dan Berkowitz is licensed in Alabama.

CMS data shows 11 Medicare services from Dan Berkowitz across 1 procedure code in 2019, for 48 Medicare patients. Medicare paid $767 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dan Berkowitz in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dan Berkowitz's median patient age at 66, with 49% women.

Dan Berkowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 111 papers to Dan Berkowitz, published from 2010 to 2025. 2017 was the busiest year, with 10. The most frequent topics are Vascular Stiffness, Mice, Inbred C57BL and Aorta. Dan Berkowitz has published most often in Anesth Analg. Dan Berkowitz's most frequent co-authors are Simran Jandu, MD, Gautam Sikka and Charles W. Hogue, MD.

CMS Open Payments shows 5 general payments to Dan Berkowitz from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 64% of the total. Abbott Laboratories paid the most, $163.